Managing diabetes in diabetic patients with COVID: where do we start from?

Angelo Avogaro1, Benedetta Bonora2, Gian Paolo Fadini2

  • 1Department of Medicine, Unit of Metabolic Disease, University of Padova, Via Giustiniani 2, 35128, Padova, Italy. angelo.avogaro@unipd.it.

Acta Diabetologica
|June 26, 2021
PubMed
Abstract

Insights

Metformin may reduce mortality risk in patients with diabetes during the COVID-19 pandemic. However, insulin might increase this risk, though data is limited by channeling bias in retrospective studies.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Pharmacology

Background:

  • The COVID-19 pandemic has overwhelmed global healthcare systems.
  • Understanding the impact of antidiabetic treatments on COVID-19 outcomes is crucial.

Purpose of the Study:

  • To review evidence on antidiabetic treatments and their association with COVID-19 mortality.
  • To identify specific antidiabetic drugs that may mitigate or exacerbate mortality risk.

Main Methods:

  • Systematic literature search of PubMed and EMBASE (March 2020 - March 2021).
  • Inclusion of studies with mortality as an outcome; exclusion of non-original research.
  • Meta-analysis for metformin and insulin using Cochrane RevMan 5.2.

Main Results:

  • Metformin was the only antidiabetic drug associated with a reduced risk of COVID-19-related mortality.
  • Insulin use appeared linked to an increased risk of mortality.
  • Other antidiabetic drug classes showed neutral associations with mortality.

Conclusions:

  • Existing evidence is largely retrospective and subject to significant channeling bias.
  • Patient phenotype influences the prescription of specific antidiabetic drugs, potentially confounding mortality results.
  • Further research is needed to clarify the true impact of antidiabetic treatments on COVID-19 mortality.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
643
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.4K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K